Quarterly ResultMay 6, 2026, 06:37 AM
Cencora Q2 Revenue $78.4B, Adjusted EPS $4.75; Raises FY26 Guidance
AI Summary
Cencora reported strong fiscal second quarter 2026 results, with revenue increasing 3.8% to $78.4 billion and adjusted diluted EPS growing 7.5% to $4.75. The company raised its fiscal year 2026 adjusted diluted EPS guidance to a range of $17.65 to $17.90, reflecting the strength of its business and strategic focus. Cencora also announced plans to repurchase $1 billion in shares by the end of calendar 2026 and declared a quarterly dividend of $0.60 per share.
Key Highlights
- Cencora Q2 fiscal 2026 revenue increased 3.8% year-over-year to $78.4 billion.
- GAAP diluted EPS was $8.40, a 128.3% increase from the prior year quarter.
- Adjusted diluted EPS rose 7.5% to $4.75 for the quarter.
- Fiscal year 2026 adjusted diluted EPS guidance raised to $17.65-$17.90.
- Company expects to repurchase $1 billion in shares by the end of calendar 2026.
- U.S. Healthcare Solutions segment revenue grew 2.9% to $68.8 billion.
- International Healthcare Solutions segment revenue increased 13.0% to $7.6 billion.
- Board declared a quarterly cash dividend of $0.60 per common share.